yeast beta-glucan

Yeast beta-glucan is an orally administered **dietary supplement** composed of beta-glucan polysaccharides derived from yeast cell walls. In the provided Huazhong University of Science and Technology trial in type 2 diabetes mellitus, it is being evaluated at **600 mg daily** as a nutritional intervention for improving glycemic control and reducing predicted atherosclerotic cardiovascular disease risk. Beta-glucans from yeast are generally understood to act as **biological response modifiers** that can influence innate immune signaling and systemic inflammation, but this study context does not identify a proprietary product, a single defined molecular target, or a commercial manufacturer. The specific development context here is investigator-sponsored clinical evaluation in adults aged 40 to 79 years with type 2 diabetes.

Brand names

Qingke β-glucan

Other names

yeast beta-glucanyeast β-glucan